Phenylacetylglutamine as a novel biomarker of type 2 diabetes with distal symmetric polyneuropathy by metabolomics

PURPOSE: Type 2 diabetes mellitus (T2DM) with distal symmetric polyneuropathy (DSPN) is a disease involving the nervous system caused by metabolic disorder, while the metabolic spectrum and key metabolites remain poorly defined. METHODS: Plasma samples of 30 healthy controls, 30 T2DM patients, and 6...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, J., Cai, M., Wang, Z., Chen, Q., Han, X., Tian, J., Jin, S., Yan, Z., Li, Y., Lu, B., Lu, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105673/
https://www.ncbi.nlm.nih.gov/pubmed/36282471
http://dx.doi.org/10.1007/s40618-022-01929-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105673/
https://www.ncbi.nlm.nih.gov/pubmed/36282471
http://dx.doi.org/10.1007/s40618-022-01929-w

Ejemplares similares